baber/WOPTO huggingface dataset:
Patent AU-2018200729-B2 (AU)
Title: Vertical takeoff and landing (VTOL) air vehicle
Inventor: TAYLOR DANA J
IPC: G05D1/08
Filed: 2018-01-25
Granted: 2019-02-07
Abstract: A flight control apparatus for fixed-wing aircraft includes a first port wing (115) and first starboard wing (120), a first port swash plate (145) coupled between a first port rotor 155) and first port electric motor (135), the first port electric 5 motor (135) coupled to the first port 5 wing (115), and a first starboard swash plate (150) coupled between a first starboard rotor (130) and first starboard electric motor (140), the first starboard electric motor (140) coupled to the first starboard wing (120). EFFECTOR GRAPHIC SYMMETRIC 100 130 100 PITCH PITCH CYCLIC (NOSE UP POSITIVE) 120-J ASYMMETRIC 130 125 2. ROLL ELEVON (RIGHT ROLL POSITIVE) POSTIE)120 110 115 ASYMMETRIC 125 110 COLLECTIVE 3. YAW (NOSE RIGHT 135 140 POSITIVE) 145 155 110 150 155 SYMMETRIC 155 125 155 130 4 THRUST COLLECTIVE (FORWARD 135 140 POSITIVE) __-_____
Patent AU-2018201596-B2 (AU)
Title: Membrane-adherent self-assembled systems for treatment of ocular disorders
Inventor: BARMAN SHIKHA P
IPC: C07J75/00
Filed: 2018-03-06
Granted: 2020-02-06
Abstract: A liquid crystalline drug delivery system for ocular administration. The drug delivery system, which is mucoadhesive, biocompatible, non-irritating, and tissue permeable, contains nanoparticles stably dispersed in an aqueous solution and can be formulated for sustained release. Also provided are methods for producing the drug 5 delivery system and methods for treating ocular disorders by administering it to a subject.
Patent AU-2018205735-B2 (AU)
Title: Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof
Inventor: PORTER DALE
IPC: A61K31/337
Filed: 2018-01-05
Granted: 2024-02-01
Abstract: A combination comprising a MCL-1 inhibitor and a taxane compound, and compositions and uses thereof.
Patent AU-2018208682-B2 (AU)
Title: Sensor system
Inventor: WORDEN BRET
IPC: G05D27/00
Filed: 2018-07-25
Granted: 2019-05-09
Abstract: A sensor system senses one or more characteristics of vehicles in a vehicle system with sensors disposed onboard the vehicles and communicate data representative of the one or more characteristics from the sensors to one or more of a controller or a control system of the vehicle system. The data communicated from the sensors onboard the same vehicle can be synchronously communicated with respect to the sensors onboard the same vehicle and asynchronously communicated with respect to the sensors disposed onboard one or more other vehicles in the vehicle system. The systems and methods can direct components disposed onboard a vehicle system to change operations, monitor data output by sensors operatively connected with the components, and determine which of the sensors are operatively connected with which of the components based on the operations of the components that are changed and the data that is output by the sensors.
Patent AU-2018214808-B2 (AU)
Title: Network visibility
Inventor: FAINBERG ILYA
IPC: H04L43/00
Filed: 2018-01-19
Granted: 2022-05-26
Abstract: Systems, methods, and related technologies for device monitoring are described. In certain aspects, network traffic data is analyzed to determine one or more devices associated with a network. The network may be a remote network. The network traffic data may further be used to determine one or more non-active devices associated with the network.
Patent AU-2018231811-B2 (AU)
Title: Fluid collection unit and related devices and methods
Inventor: SHI QINWEI
IPC: A61B10/00
Filed: 2018-03-08
Granted: 2023-04-20
Abstract: Described herein is a fluid collection unit comprising: a receptacle for passively collecting a fluid sample; and a fluid flow path in fluid communication with the receptacle, the fluid flow path passing through the unit for directing the fluid sample from the receptacle to an opposing end of the unit.
Patent AU-2018247336-B2 (AU)
Title: Topical co-enzyme q10 formulations and methods of use
Inventor: HSIA LAN SUNG
IPC: A61K31/35
Filed: 2018-10-12
Granted: 2019-12-19
Abstract: Topical formulations of CoQ1O reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ1O was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ1O was shown to dramatically reduce the rate of tumor growth in the animals.
Patent AU-2018253620-B2 (AU)
Title: Injectable botulinum toxin formulations
Inventor: RUEGG CURTIS L
IPC: A61K39/08
Filed: 2018-10-26
Granted: 2020-10-29
Abstract: This invention provides novel injectable compositions comprising 
botulinum toxin that may be administered to a subject for various therapeutic, 
aesthetic and/or cosmetic purposes. The injectable compositions contemplated by the 
invention exhibit one or more advantages over conventional botulinum toxin 
formulations, including reduced antigenicity, a reduced tendency to undergo 
unwanted localized diffusion following injection, increased duration of clinical 
efficacy or enhanced potency relative, faster onset of clinical efficacy, and/or 
improved stability.
Patent AU-2018267595-B2 (AU)
Title: Treatment of infection
Inventor: MCCLOSKEY JENNY COLLEEN
IPC: A61K39/39
Filed: 2018-11-21
Granted: 2020-09-03
Abstract: The invention relates to compositions including a substance useful as an adjuvant for 
potentiating an immune response, and methods of using the composition in individuals 
with infections of tissue within or adjacent to a transformation zone, such as the 
5 transformation zone of the cervix or anal canal.
Patent AU-2018348767-B2 (AU)
Title: Non-fired monoliths
Inventor: HERTEL TOBIAS
IPC: C04B28/00
Filed: 2018-10-11
Granted: 2023-07-06
Abstract: The invention relates to methods for manufacturing an inorganic polymer object from a precursor wherein the precursor consists of one or more or comprises one or more selected from the group consisting of gibbsite-containing bauxite, gibbsitecontaining residue of the Bayer process, thermally processed gibbsite-containing bauxite, and thermally processed gibbsite-containing residue of the Bayer process, the method comprising the steps of alkaline-activating said precursor, mixing the precursor, shaping the mixed precursor and hydrothermally curing the shaped precursor at a temperature between 70 °C and 350 °C.
Patent AU-2018352382-B2 (AU)
Title: Compounds and methods for treating cancer
Inventor: D'ANDREA ALAN
IPC: C07D311/04
Filed: 2018-10-16
Granted: 2022-06-02
Abstract: The present application provides, in some aspects, methods of treating cancers, such as homologous recombination (HR)-deficient cancers. In some embodiments, the disclosure provides a method for treating cancer by administering to a subject a compound of Formula (I) : (I), or a pharmaceutically acceptable salt thereof.
Patent AU-2018384620-B2 (AU)
Title: Wipes dispensers and easy load adjustable dispensing nozzle
Inventor: MANN CHRISTOPHER J
IPC: A47K10/38
Filed: 2018-12-06
Granted: 2023-06-01
Abstract: Embodiments of dispensers for dispensing wet wipes are disclosed herein. An exemplary dispenser includes a container, a plurality of wipes, and a wipes dispensing nozzle. The wipes dispensing nozzle has a first housing member and a second housing member that are movable between a first position and a second position. In the first position, the wipes dispensing nozzle has an opening that has a first diameter. In the second position, the nozzle has an opening that has a second diameter that is smaller than the first diameter. When the nozzle is in the first position, a lead wipe of the plurality of wipes may be threaded through the wipes dispensing nozzle. In the first position, the wipes dispensing nozzle does not exert sufficient frictional force against a trailing wipe to cause the lead wipe to separate from the trailing wipe along a perforation line. In the second position, the wipes nozzle is in a closed dispensing position.
Patent AU-2019201540-B2 (AU)
Title: Uav configurations and battery augmentation for uav internal combustion engines, and associated systems and methods
Inventor: MCADOO GREGORY LEONARD
IPC: B64C27/08
Filed: 2019-03-06
Granted: 2021-03-18
Abstract: UAV configurations and battery augmentation for UAV internal combustion engines, and 
associated systems and methods are disclosed. A representative configuration includes a 
fuselage, first and second wings coupled to and pivotable relative to the fuselage, and a plurality 
of lift rotors carried by the fuselage. A representative battery augmentation arrangement 
includes a DC powered motor, an electronic speed controller, and a genset subsystem coupled 
to the electronic speed controller. The genset subsystem can include a battery set, an alternator, 
and a motor-gen controller having a phase control circuit configurable to rectify multiphase 
AC output from the alternator to produce rectified DC feed to the DC-powered motor. The 
motor-gen controller is configurable to draw DC power from the battery set to produce the 
rectified DC feed.
WO 2015/138217 PCT/US2015/019004 
1/24 
0 ~xM 
0 0 
C~) C~) 
co Oo 
00 
C
ro 2 C 
C0 
>n 
.E-0 -0 
0 Ca 00J)I 
ITi o- U
Patent AU-2019326288-B2 (AU)
Title: System and method for unique identifier detection based on invisible light
Inventor: GABRIEL MICHAEL RICHARD
IPC: G06K19/06
Filed: 2019-07-26
Granted: 2021-04-01
Abstract: An invisible light sensing device senses invisible light from a plurality of invisible light emitting objects in which each of the invisible light emitting objects emits invisible light in an identification pattern that is distinct from other identification patterns. An identification pattern is based on one or more apertures through which invisible light is emitted to form the identification pattern. An identification pattern is also based on a plurality of invisible light emitters in which at least a portion of the invisible light emitters are positioned and activated to form the identification pattern.
Patent AU-2020202927-B2 (AU)
Title: Occluder and anastomosis devices
Inventor: JOHNSON MATTHEW A
IPC: A61B17/12
Filed: 2020-05-01
Granted: 2022-05-12
Abstract: An medical device for sealing a defect or structure in tissue, the device 
including: a frame including an elongate member, the frame defining: an 
apposition portion; a sealing portion; and a defect-occupying portion 
disposed between the apposition portion and the sealing portion, and a 
covering material disposed on at least a portion of the sealing portion, 
wherein the apposition portion contains a plurality of apposition petals, 
wherein the sealing portion contains a plurality of sealing petals, and 
wherein the apposition petals and the sealing petals have a pre-strained 
geometry such that an apposition force exists in the absence of a tissue 
layer.  
12291687_1 (GHMatters) P104115.AU.2
20/23 
2411 
2413 
FIG. 20 
2400a 
2450a 
2410 
. 212411 
FIG. 21
Patent AU-2020203017-B2 (AU)
Title: Interface Comprising a Rolling Nasal Bridge Portion
Inventor: OLSEN GREGORY JAMES
IPC: A61M16/06
Filed: 2020-05-07
Granted: 2021-11-18
Abstract: An interface for positive pressure therapy includes a mask assembly, a headgear 
assembly and a connection port assembly. The mask assembly comprises a seal member that 
has an upper portion movably connected to an integrated lower portion, wherein the upper 
portion rolls during hinging movement of the upper portion relative to the lower portion. The 
headgear assembly allows connection to the mask assembly in a direction substantially 
normal to a direction of strap tension. The connection port assembly includes a swivel elbow 
with a valve member that controls flow through a port that opens toward the user.  
-58-
/52 
150 
/02 
F116 
11/64
Patent AU-2021214350-B2 (AU)
Title: 3-alkoxybenzamide derivative, and pest control agent
Inventor: TANAKA KOSUKE
IPC: C07C235/46
Filed: 2021-01-29
Granted: 2023-08-24
Abstract: The present invention provides: a 3-alkoxy benzoic acid amide derivative having an excellent pest control effect, or a salt thereof; and a pest control agent and a production intermediate which contain the same as an active ingredient.　Provided are: a 3-alkoxy benzoic acid amide derivative represented by general formula [I] [In the formula, A represents an oxygen atom or a sulfur atom, G represents a hydrogen atom, a halogen atom, or a C
Patent AU-2021314940-B2 (AU)
Title: Use of piperdine-1-carbodithioic acid-3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylmethyl ester
Inventor: SUN CHENG
IPC: A61K31/4453
Filed: 2021-09-05
Granted: 2022-05-19
Abstract: i N j 9(- WJP? I IN -Ef |EP $ l 
(119)M
'43 PdVT WO 2022/022748 A1 
2022 4 2 J- 3 (03.02.2022) WIPO I PCT 
(51) ) -J 3 : (81) 1 ) H ,f { 
A61K31/4453(2006.01) A61P25/16(2006.01) {ffp): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, 
(21)j3 PCT/CN2021/116577 BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, 
CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, Fl, GB, 
(22) M p $( EH : 2021 4 9 )] 5 H (05.09.2021) GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, IT, 
(25) $ i gj F: JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, 
LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, 
(26) Qt : MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, 
(30)VLt.: PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, 
202110095726.8 202141)A25H (25.01.2021) CN ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, 
(71) $iO:it * (NANTONG UNIVERSITY) [CN/ UZ, VC, VN, WS, ZA, ZM, ZWc 
CN] + lT i -H11 6 WM9 (8 4) -M(j 4 h rH, V R -f lTtJ A-kZ -AE 
, Jiangsu 226000 (CN)o   fgf): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, 
(72)&PA:TIJI(SUN,Cheng); + Pd I LNA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), R Il (AM, 
(72) P I) Afl : M 9 (SUNing); 226000 ( . -11)] AZ, BY, KG, KZ, RU, TJ, TM), +II (AL, AT, BE, BG, 
S H 9 , Jiangsu226000 (CN)o .~ I CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, 
TA (WANG, Yuejun); + P T N M iil I IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, 
- LHl 9 Jiangsu226000(CN)°   RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, 
(74) tgTA: M Mif j - flJ $ - §- g( i-j CM, GA, GN, GQ GW, KM, ML, MR, NE, SN, TD, TG).  
Q) (NANTONG YONGTONG PATENT AGENCY); 
F I Pd @ IT M LM ri )11 1 L V 11 I )I 
A12-2302, Jiangsu 226000 (CN)o 
(54) Title: USE OF PIPERDINE-1-CARBODITHIOIC ACID-3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL
METHYL ESTER 
(57) Abstract: Disclosed in the present invention is use of piperdine-1-carbodithioic acid-3-methyl-1,4-dioxo-1,4-dihydronaph
thalen-2-ylmethyl ester, which is application in the treatment of Parkinson's disease. Experimental results of the present invention show 
that when PKM2-IN-1 is administered to Parkinson's disease (PD) model mice by means of an intragastric administration method, it 
is found that the medicine can significantly alleviate PD-related symptoms, such as restore the number of dopaminergic neurons in 
the substantia nigra part, improve the expression of tyrosine hydroxylase at the midbrain part and improve the exercise capacity and 
olfactory function of the mice.  
(57) MR : * a HA TF J' - T * )t -1- AL ft P & -3- FP &1, 4 - A -1, 4 - -2 - FP A n M 9 
-T CA PKM2-N-1, a ), AI PTW r PDHCi U, 4H fky TAJ-.1 A!B ERjii$-M
W O 2022/022748 A 1 ||1111|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
t4RVAEMWJ4.17 PAlR: 
- +T X AMj(pJg4. 17(i)) 
- +T ( $ $(M9J 
4.17(ii)) 
- + TA 4hXR v $A Alt4) AR(M 9]J1 
4.17(iii)) 
- tWAi&(ltJ417 (i(v) 
- tiM P F;-, ( i , M2 1 *(3)) 
MBA)R2%fr$(MW4 8. 2 (h)) 
-~T 2E1AQ1* &(2) (a) Ffr ft
Patent AU-2022200032-B2 (AU)
Title: Prach and/or srs switching enhancements
Inventor: RICO ALVARINO ALBERTO
IPC: H04L5/00
Filed: 2022-01-05
Granted: 2023-08-10
Abstract: Certain aspects of the disclosure relate to techniques and apparatus for 
improving random access for SRS switching in a wireless network. Prior to 
transmitting a SRS, a UE may interrupt communication on a first carrier to switch from 
the first carrier to a second carrier to transmit a PRACH. To reduce interruption to the 
first carrier, the UE may use the beginning symbol(s) of a UpPTS on the second carrier 
to transmit the PRACH. In addition, to reduce interruption to the first carrier, the UE 
may monitor for another PDCCH order before transmitting another PRACH. Further, 
aspects of the present disclosure provide techniques and apparatus for jointly triggering 
SRS transmissions and performing power control for SRS transmissions. A BS may 
trigger SRS transmissions from multiple UEs, trigger SRS transmissions from multiple 
carriers from the same UE at the same time and/or perform power control separately for 
each carrier.
Patent AU-2022281288-B2 (AU)
Title: Methods and systems for using an unmanned aerial vehicle (UAV) dedicated to deployment of operational infrastructure
Inventor: BLAKE JESSE
IPC: G05D1/00
Filed: 2022-12-05
Granted: 2023-08-31
Abstract: METHODS AND SYSTEMS FOR USING AN UNMANNED AERIAL VEHICLE 
(UAV) DEDICATED TO DEPLOYMENT OF OPERATIONAL 
INFRASTRUCTURE 
ABSTRACT 
Example implementations may relate to using an unmanned aerial vehicle (UAV) dedicated to 
deployment of operational infrastructure, with such deployment enabling charging of a battery 
of a UAV from a group of UAVs. More specifically, the group of UAVs may include at least 
(i) a first UAV of a first type configured to deploy operational infrastructure and (ii) a second 
UAV of a second type configured to carry out a task other than deployment of operational 
infrastructure. With this arrangement, a control system may determine an operational location 
at which to deploy operational infrastructure, and may cause the first UAV to deploy 
operational infrastructure at the operational location. Then, the control system may cause the 
second UAV to charge a battery of the second UAV using the operational infrastructure 
deployed by the first UAV at the operational location.
Patent JP-3973340-B2 (JP)
IPC: H01L23/12
Filed: 2000-03-02
Granted: 2007-09-12
Abstract: In accordance with the present invention, during formation of the interconnection board, the interconnection board remains securely fixed to a high rigidity plate being higher in rigidity than the interconnection board for suppressing the interconnection board from being bent. <IMAGE>
Patent JP-3481548-B2 (JP)
IPC: B23D51/03
Filed: 2000-04-12
Granted: 2003-12-22
Abstract: In a folding saw in which either the edge of the blade, the handle or both are curved, to prevent the edge of the blade from being exposed when blade is folded so that the saw can be handled safely, a protective cover 4 in which the edge 1a of the blade 1 can be nestled is placed inside the housing groove 3 of the handle 2 having a semi-U-shaped cross section for housing the blade 1. The protective cover 4 is retractable with respect to the housing groove 3, and when the blade is folded, projects out of the housing groove 3 and covers the edge 1a, which may be exposed. The protective cover 4 is preferably energized by a spring so that it covers the edge 1a whenever the blade is folded. <IMAGE>
Patent JP-3781624-B2 (JP)
IPC: F16F9/12
Filed: 2000-12-22
Granted: 2006-05-31
Abstract: A rotary damper has an outer tube 13 having a tubular space 37 with its one end closed in the tube wall, and an inner tube 12 having a tubular space 27 with its one end closed in the tube wall and being smaller in diameter than the outer tube. An outer wall 21 of the inner tube 12 is inserted into a tubular space 37 of the outer tube 13, whereas an inner wall 32 of the outer tube 13 is inserted into the space 27. O-rings are installed in end portions on the open sides of the respective gaps between an outer wall 31 of the outer tube 13 and an inner wall 12 and between the inner wall 32 and the inner wall 22 of the inner tube 12, and the gap between the inner and outer tubes 12 and the 13 is replete with viscous substance. <IMAGE>
Patent JP-4831864-B2 (JP)
IPC: C07K14/015
Filed: 1998-12-03
Granted: 2011-12-07
Abstract: The invention relates to nucleic sequences derived from a human erythrovirus type V9, fragments of the sequences and their methods of use including applications as a diagnostic reagent and as immunogenic agent.
Patent JP-4695259-B2 (JP)
IPC: A61P43/00
Filed: 1999-03-16
Granted: 2011-06-08
Abstract: 1-Oxo- and 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindolines of formula (I) in which Y is oxygen or H2, one of R<1> and R<2> is halo, alkyl, alkoxy, alkylamino, dialkylamino, cyano, or carbamoyl, the other of R<1> and R<2> is independently hydrogen, halo, alkyl, alkoxy, alkylamino, dialkylamino, cyano, or carbamoyl and; R<3> is hydrogen, alkyl, or benzyl, and the method of reducing levels of tumor necrosis factor  PROPORTIONAL  and other inflammatory cytokines in a mammal through the administration of such derivatives, and pharmaceutical compositions containing such derivatives. <CHEM>
Patent JP-3695642-B2 (JP)
IPC: G01N33/50
Filed: 1999-11-30
Granted: 2005-09-14
Abstract: Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy. In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Patent JP-4616482-B2 (JP)
IPC: E04B1/76
Filed: 1999-12-16
Granted: 2011-01-19
Abstract: The microporous heat insulation body consists of a compressed heat insulation material containing from 30 to 90% by weight of a finely divided metal oxide, from 0 to 30% by weight of an opacifier, from 0 to 10% by weight of an inorganic fibrous material, and from 0 to 15% by weight of an inorganic binder, and additionally from 2 to 45% by weight, preferably from 5 to 15% by weight of xonotlite.
Patent JP-4623537-B2 (JP)
IPC: B06B1/02
Filed: 2001-01-24
Granted: 2011-02-02
Abstract: An ultrasound probe is described for ultrasound imaging using contrast enhancing agents and comprising two interleaved arrays of transducer elements (102,111), each of said arrays having a longitudinal dimension along which the transducer elements are placed side by side, a first one of the interleaved arrays comprising transducer elements having a lower center frequency and a second one of the interleaved arrays comprising transducer elements having a higher center frequency. The transducer elements of the first interleaved array are provided on a first, hollow, support member (101). The transducer elements of the second interleaved array are provided on a second support member. The second support member fits within the first support member. A length of the transducer elements of the first array in a plane of the array and in a direction substantially perpendicular to the longitudinal dimension is larger than a corresponding length of elements of the second array. The corresponding length of the transducer elements of the second array is not larger than a corresponding inside measure of the first, hollow, support member. <IMAGE>